 |
 |
 |
|
|
|
|
We are unique in that our services are priced significantly below the prevailing market rate. This is an exceptional value for our customers, as biotechnology companies frequently face severe cash constraints and need to successfully reach product development milestones in order to secure additional funding from investors. We are able to price our services below other contract research organizations (CROs) because we conduct studies in leading research centers located in Central Europe, where labor and other costs are lower than in the U.S. or Western Europe. |
|
